Literature DB >> 32365233

Guidelines for the management of diabetes services and patients during the COVID-19 pandemic.

G Rayman1, A Lumb2, B Kennon3, C Cottrell4, D Nagi5, E Page1, D Voigt6, H Courtney7, H Atkins8, J Platts9, K Higgins8, K Dhatariya10, M Patel11, P Narendran12, P Kar13, P Newland-Jones11, R Stewart14, O Burr15, S Thomas16.   

Abstract

The UK National Diabetes Inpatient COVID Response Group was formed at the end of March 2020 to support the provision of diabetes inpatient care during the COVID pandemic. It was formed in response to two emerging needs. First to ensure that basic diabetes services are secured and maintained at a time when there was a call for re-deployment to support the need for general medical expertise across secondary care services. The second was to provide simple safe diabetes guidelines for use by specialists and non-specialists treating inpatients with or suspected of COVID-19 infection. To date the group, comprising UK-based specialists in diabetes, pharmacy and psychology, have produced two sets of guidelines which will be continually revised as new evidence emerges. It is supported by Diabetes UK, the Association of British Clinical Diabetologists and NHS England.
© 2020 Diabetes UK.

Entities:  

Mesh:

Year:  2020        PMID: 32365233     DOI: 10.1111/dme.14316

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  14 in total

1.  Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?

Authors:  Theocharis Koufakis; Symeon Metallidis; Pantelis Zebekakis; Ramzi A Ajjan; Kalliopi Kotsa
Journal:  J Diabetes Sci Technol       Date:  2020-06-02

2.  Virtual triage and outcomes of diabetic foot complications during Covid-19 pandemic: A retro-prospective, observational cohort study.

Authors:  Ashu Rastogi; Priya Hiteshi; Anil Bhansali A; Edward B Jude
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

3.  Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic.

Authors:  Ioannis Kyrou; Emmanouil Karteris; Tim Robbins; Kamaljit Chatha; Fotios Drenos; Harpal S Randeva
Journal:  BMC Med       Date:  2020-07-15       Impact factor: 8.775

4.  COVID-19 and diabetes: No time to drag our feet during an untimely pandemic.

Authors:  Ioannis Kyrou; Tim Robbins; Harpal S Randeva
Journal:  J Diabetes Complications       Date:  2020-05-15       Impact factor: 2.852

5.  Diabetes and COVID-19: Global and regional perspectives.

Authors:  In-Kyung Jeong; Kun Ho Yoon; Moon Kyu Lee
Journal:  Diabetes Res Clin Pract       Date:  2020-07-03       Impact factor: 5.602

Review 6.  SARS-CoV-2 (COVID-19) and the Endocrine System.

Authors:  Michelle D Lundholm; Caroline Poku; Nicholas Emanuele; Mary Ann Emanuele; Norma Lopez
Journal:  J Endocr Soc       Date:  2020-10-01

7.  SGLT-2 inhibitors as cardioprotective agents in COVID-19.

Authors:  Kashish Gupta; Shekhar Kunal
Journal:  Heart Lung       Date:  2020-09-22       Impact factor: 2.210

8.  The impact of the COVID-19 pandemic on people with diabetes and diabetes services: A pan-European survey of diabetes specialist nurses undertaken by the Foundation of European Nurses in Diabetes survey consortium.

Authors:  Rita Forde; Liga Arente; Davide Ausili; Kristin De Backer; Mette Due-Christensen; Amanda Epps; Anne Fitzpatrick; Moira Grixti; Sijda Groen; Arja Halkoaho; Claudia Huber; Marjolein M Iversen; Unn-Britt Johansson; Claudia Leippert; Seyda Ozcan; Julie Parker; Ana Christina Paiva; Adina Sanpetreanu; Marie-Alice Savet; Svetic-Cisic Rosana; Alicja Szewczyk; Maite Valverde; Eugenia Vlachou; Angus Forbes
Journal:  Diabet Med       Date:  2020-12-30       Impact factor: 4.213

Review 9.  Impact of diabetes on COVID-19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors-East Meets West Symposium.

Authors:  Andrea O Y Luk; Susanna S S Ng; Richard I G Holt
Journal:  Diabet Med       Date:  2021-03-02       Impact factor: 4.213

10.  Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19.

Authors:  Faruque Pathan; Shahjada Selim; Md Fariduddin; Md Hafizur Rahman; S M Ashrafuzzaman; Faria Afsana; Nazmul Kabir Qureshi; Tanjina Hossain; M Saifuddin; A B Kamrul-Hasan; Ahmed Salam Mir
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-18       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.